Feasibility of Transvaginal Natural Orifice Transluminal Endoscopic Surgery–Assisted Living Donor Nephrectomy: Is Kidney Vaginal Delivery the Approach of the Future?
Antonio Alcaraz(Hospital Clínic de Barcelona), María J. Ribal(Hospital Clínic de Barcelona), Josep M. Campistol(Universitat de Barcelona), Federico Oppenheimer(Hospital Clínic de Barcelona), R. Álvarez-Vijande(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Mireía Musquera(Surgical Specialties (Canada)), Lluís Peri(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Laura Izquierdo(Hospital Clínic de Barcelona), E. Garcı́a-Cruz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), J. Huguet(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 92
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration
|Cell stem cell|2014|201